Amundi’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Amundi's ATRC Position: Q2 2026 in Review
Amundi increased its AtriCure (ATRC) stake by 17% in Q2 2026, buying an estimated $1.1M and bringing the position to 264,854 shares worth $7.41M. The position accounts for ﹤0.01% of the portfolio, ranked #954.
Amundi first reported a position in ATRC in Q3 2022 and has held it in 16 quarters since. The position peaked at $10.2M in Q4 2023. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Amundi held 264,854 shares of AtriCure worth $7.41M as of Q2 2026.
- Amundi bought 38,922 AtriCure shares in Q2 2026, an estimated $1.1M.
- AtriCure made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #954 holding.
- Amundi first reported a position in AtriCure in Q3 2022 and has held it in 16 quarters since.
- Amundi's AtriCure position peaked at $10.2M in Q4 2023.
- 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.